These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25358680)

  • 1. Voyage au bout de la nuit: Aβ and tau imaging in dementias.
    Zwan MD; Okamura N; Fodero-Tavoletti MT; Furumoto S; Masters CL; Rowe CC; Villemagne VL
    Q J Nucl Med Mol Imaging; 2014 Dec; 58(4):398-412. PubMed ID: 25358680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau imaging in the study of ageing, Alzheimer's disease, and other neurodegenerative conditions.
    Villemagne VL; Okamura N
    Curr Opin Neurobiol; 2016 Feb; 36():43-51. PubMed ID: 26397020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tau imaging: early progress and future directions.
    Villemagne VL; Fodero-Tavoletti MT; Masters CL; Rowe CC
    Lancet Neurol; 2015 Jan; 14(1):114-24. PubMed ID: 25496902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo tau imaging: obstacles and progress.
    Villemagne VL; Okamura N
    Alzheimers Dement; 2014 Jun; 10(3 Suppl):S254-64. PubMed ID: 24924676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aβ-amyloid and Tau Imaging in Dementia.
    Villemagne VL; Doré V; Bourgeat P; Burnham SC; Laws S; Salvado O; Masters CL; Rowe CC
    Semin Nucl Med; 2017 Jan; 47(1):75-88. PubMed ID: 27987560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tau Positron Emission Tomography].
    Higuchi M
    Brain Nerve; 2017 Jul; 69(7):819-823. PubMed ID: 28739996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions.
    Villemagne VL; Doré V; Burnham SC; Masters CL; Rowe CC
    Nat Rev Neurol; 2018 Apr; 14(4):225-236. PubMed ID: 29449700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long night's journey into the day: amyloid-β imaging in Alzheimer's disease.
    Villemagne VL; Rowe CC
    J Alzheimers Dis; 2013; 33 Suppl 1():S349-59. PubMed ID: 22710919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular imaging of dementia.
    Mori T; Maeda J; Shimada H; Higuchi M; Shinotoh H; Ueno S; Suhara T
    Psychogeriatrics; 2012 Jun; 12(2):106-14. PubMed ID: 22712644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease.
    Xia CF; Arteaga J; Chen G; Gangadharmath U; Gomez LF; Kasi D; Lam C; Liang Q; Liu C; Mocharla VP; Mu F; Sinha A; Su H; Szardenings AK; Walsh JC; Wang E; Yu C; Zhang W; Zhao T; Kolb HC
    Alzheimers Dement; 2013 Nov; 9(6):666-76. PubMed ID: 23411393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polypathology and dementia after brain trauma: Does brain injury trigger distinct neurodegenerative diseases, or should they be classified together as traumatic encephalopathy?
    Washington PM; Villapol S; Burns MP
    Exp Neurol; 2016 Jan; 275 Pt 3(0 3):381-388. PubMed ID: 26091850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of global and cerebellar normalization on detection and differentiation of dementia in FDG-PET studies.
    Dukart J; Mueller K; Horstmann A; Vogt B; Frisch S; Barthel H; Becker G; Möller HE; Villringer A; Sabri O; Schroeter ML
    Neuroimage; 2010 Jan; 49(2):1490-5. PubMed ID: 19770055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo characterization of chronic traumatic encephalopathy using [F-18]FDDNP PET brain imaging.
    Barrio JR; Small GW; Wong KP; Huang SC; Liu J; Merrill DA; Giza CC; Fitzsimmons RP; Omalu B; Bailes J; Kepe V
    Proc Natl Acad Sci U S A; 2015 Apr; 112(16):E2039-47. PubMed ID: 25848027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid Aβ40 is similarly reduced in patients with Frontotemporal Lobar Degeneration and Alzheimer's Disease.
    Baldeiras I; Santana I; Leitão MJ; Ribeiro MH; Pascoal R; Duro D; Lemos R; Santiago B; Almeida MR; Oliveira CR
    J Neurol Sci; 2015 Nov; 358(1-2):308-16. PubMed ID: 26388316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Accuracy of Cerebrospinal Fluid Amyloid-β Isoforms for Early and Differential Dementia Diagnosis.
    Struyfs H; Van Broeck B; Timmers M; Fransen E; Sleegers K; Van Broeckhoven C; De Deyn PP; Streffer JR; Mercken M; Engelborghs S
    J Alzheimers Dis; 2015; 45(3):813-22. PubMed ID: 25633670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developments in Tau PET Imaging.
    Zimmer ER; Leuzy A; Gauthier S; Rosa-Neto P
    Can J Neurol Sci; 2014 Sep; 41(5):547-53. PubMed ID: 25424608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the development of tau PET radiotracers and their clinical applications.
    Okamura N; Harada R; Furukawa K; Furumoto S; Tago T; Yanai K; Arai H; Kudo Y
    Ageing Res Rev; 2016 Sep; 30():107-13. PubMed ID: 26802556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pittsburgh compound B-negative dementia: a possibility of misdiagnosis of patients with non-alzheimer disease-type dementia as having AD.
    Shimada H; Ataka S; Takeuchi J; Mori H; Wada Y; Watanabe Y; Miki T
    J Geriatr Psychiatry Neurol; 2011 Sep; 24(3):123-6. PubMed ID: 21750305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortical laminar binding of PET amyloid and tau tracers in Alzheimer disease.
    Li Y; Tsui W; Rusinek H; Butler T; Mosconi L; Pirraglia E; Mozley D; Vallabhajosula S; Harada R; Furumoto S; Furukawa K; Arai H; Kudo Y; Okamura N; de Leon MJ
    J Nucl Med; 2015 Feb; 56(2):270-3. PubMed ID: 25572087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.